Ileostomy - StomaNCT01957462
Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy
A study testing Coloplast Test V and Coloplast Test X in people with Ileostomy - Stoma and Colostomy - Stoma, run by Coloplast A/S at 1 site in Denmark.
Trial summary
The aim of the current investigation is to develop new soft and more flexible 1-piece convex ostomy products. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Ileostomy - Stoma, Colostomy - Stoma
- What is being tested?
- Coloplast Test V and Coloplast Test X
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteDenmark
- Study dates
- Apr 2013to May 2013
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Have given written informed consent and signed letter of authority.
- Are at least 18 years of age and have full legal capacity.
- Have had their ostomy (ileo- or colostomy) for at least 3 months.
- Have used a 1-piece convex ostomy product during the last month.
- Are willing and able to comply with investigation procedures.
- Have a ostomy with a diameter of 33 mm or less.
Who cannot join
- Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy.
- Currently receiving or have within the past month received local (peristomal area) or systemic steroid treatment.
- Are pregnant or breastfeeding.
- Have a loop ostomy (also called double-barrel or ostomy with two outlets).
- Known hypersensitivity toward any of the test products.
- Use irrigation during the investigation (flush the stoma with water).
- Participating in other interventional clinical investigations or have previously participated in this investigation.
Trial locations and contacts
1 site in 1 country.
About this study
The aim of the current investigation is to develop new soft and more flexible 1-piece convex ostomy products.
- Conditions
- Ileostomy - Stoma, Colostomy - Stoma
- Being tested
- Coloplast Test V, Coloplast Test X
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Coloplast Test VDevice
Also called Coloplast 1-piece convex Test product V
Coloplast Test product V is a newly developed 1-piece ostomy appliance
Coloplast Test XDevice
Also called Coloplast 1-piece convex Test product X
Coloplast Test X is a newly developed 1-piece ostomy appliance
| Study group | Role | What they receive |
|---|---|---|
| FirstColplast Test V, Then Coloplast Test X | Experimental | The subject tests two experimental coloplast products in a randomised order. Coloplast Test product V and after cross over ColoplastTest product X Receives: Device: Coloplast Test V; Device: Coloplast Test X |
| First Coloplast Test X, Then Coloplast Test V | Experimental | The subjects test the two experimental Coloplast products in a randomised order: Coloplast Test product X and after cross over Coloplast Test product V Receives: Device: Coloplast Test V; Device: Coloplast Test X |
What is being measured
The primary outcome is the main question the study is designed to answer.
Degree of Leakage
The degree of leakage is measured using a 32-point scale developed by Coloplast A/S, where 0 represents No leakage (the best possible outcome) and 32 points represents full plate leakage (worst possible outcome).
The degree of leakage is measured at each baseplate change
Measured: 14 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2013 (estimated)
- Study startApr 2013
- Primary completionMay 2013
- Study completionMay 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Ileostomy - StomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Coloplast A/S
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Birte P Jakobsen, MD, Principal investigator, Coloplast A/S
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01957462
- Sponsor's protocol ID
- CP239
- Status last verified
- Aug 2016
- First submitted
- 6 Aug 2013
- Last updated
- 26 Sep 2016
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy
- ClinicalTrials.gov ID
- NCT01957462
- Acronym / sponsor ID
- CP239
- Conditions
- Ileostomy - Stoma, Colostomy - Stoma
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- Coloplast A/SIndustry (pharma, biotech, devices)
- Study start
- Apr 2013
- Primary completion
- May 2013 (actual)
- Study completion
- May 2013 (actual)
- First posted
- 8 Oct 2013 (estimated)
- Results
- Posted 11 Aug 2014
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the current investigation is to develop new soft and more flexible 1-piece convex ostomy products.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| FirstColplast Test V, Then Coloplast Test X | Experimental | Device: Coloplast Test V, Device: Coloplast Test XThe subject tests two experimental coloplast products in a randomised order. Coloplast Test product V and after cross over ColoplastTest product X |
| First Coloplast Test X, Then Coloplast Test V | Experimental | Device: Coloplast Test V, Device: Coloplast Test XThe subjects test the two experimental Coloplast products in a randomised order: Coloplast Test product X and after cross over Coloplast Test product V |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Have given written informed consent and signed letter of authority.
- Are at least 18 years of age and have full legal capacity.
- Have had their ostomy (ileo- or colostomy) for at least 3 months.
- Have used a 1-piece convex ostomy product during the last month.
- Are willing and able to comply with investigation procedures.
Key exclusion criteria (8 listed)
- Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy.
- Currently receiving or have within the past month received local (peristomal area) or systemic steroid treatment.
- Are pregnant or breastfeeding.
- Have a loop ostomy (also called double-barrel or ostomy with two outlets).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Coloplast Test VAlso: Coloplast 1-piece convex Test product VColoplast Test product V is a newly developed 1-piece ostomy appliance | Device | First Coloplast Test X, Then Coloplast Test V, FirstColplast Test V, Then Coloplast Test X |
| Coloplast Test XAlso: Coloplast 1-piece convex Test product XColoplast Test X is a newly developed 1-piece ostomy appliance | Device | First Coloplast Test X, Then Coloplast Test V, FirstColplast Test V, Then Coloplast Test X |
Primary outcome
Degree of Leakage
Time frame: 14 days
The degree of leakage is measured using a 32-point scale developed by Coloplast A/S, where 0 represents No leakage (the best possible outcome) and 32 points represents full plate leakage (worst possible outcome). The degree of leakage is measured at each baseplate change
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Sep 2016.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Ileostomy - Stoma
Not yet recruiting
Suture Choice for Ostomy Creation
Ostomy - Ileostomy or Colostomy, Stoma Complications
Active, not recruitingPhase 2
Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy
Crohn's Disease
Active, not recruiting
The Effect of Planned Group Interaction on Ostomy Adaptation, Quality of Life, and Stoma Care Self-Efficacy Levels in Individuals With an Ostomy
Ostomy - Ileostomy or Colostomy
Recruiting
Novel Post-Surgical Incision Management to Prevent Ostomy Complications
Ostomy, Enterocutaneous Fistula
RecruitingObservational study
Exploratory Study of Peristomal and Non-Peristomal Skin Barrier Characteristics in People With a Stoma
Colostomy - Stoma, Ileostomy - Stoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Birte P Jakobsen, MD principal investigator
Coloplast A/S
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Coloplast Test V and Coloplast Test X in people with Ileostomy - Stoma and Colostomy - Stoma, run by Coloplast A/S at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 11 Aug 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Degree of Leakage (time frame: 14 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2016.